Company Filing History:
19 out of 998 
1 out of 1,747 
Years Active: 2009-2022
Title: Innovations by Michael Blaber: A Pioneer in Synthetic Proteins
Introduction: Michael Blaber, based in Tallahassee, Florida, is a prominent inventor with a remarkable portfolio of 19 patents. His work primarily focuses on synthetic proteins and their applications, showcasing his innovative approach to biochemistry and molecular biology.
Latest Patents: Among his recent patents, two stand out for their groundbreaking contributions to the field. The first patent, titled "Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins," describes a novel method for producing synthetic foldable proteins that emulate the tertiary structures of reference proteins. This process involves determining a folding nucleus peptide sequence essential for folding the reference protein and synthesizing the synthetic protein accordingly.
The second patent, "Fibroblast growth factor mutants having improved functional half-life and methods of their use," presents variants of fibroblast growth factor (FGF) proteins with significant sequence alignment to human FGF-1. These mutants incorporate specific amino acid substitutions that enhance their functionality and are designed for medical applications, particularly in treating ischemic conditions and tissue injuries.
Career Highlights: Michael Blaber's distinguished career includes significant roles at the Florida State University Research Foundation, Inc. and the Mayo Foundation for Medical Education and Research. His experience in these reputable institutions has facilitated his contributions to scientific research and innovation.
Collaborations: Throughout his career, Blaber has collaborated with notable colleagues such as Jihun Lee and Vikash Kumar Dubey. These partnerships have enriched his research endeavors and resulted in advancements in the understanding and application of synthetic proteins.
Conclusion: Michael Blaber's contributions to the field of synthetic proteins and their therapeutic potential reflect his commitment to innovation in science. With an impressive number of patents and collaborative efforts with esteemed professionals, he continues to play a vital role in advancing medical research and applications. Through his work, Blaber exemplifies the spirit of innovation that drives the scientific community forward.